Business Description
S2Medical AB
ISIN : SE0011725084
Share Class Description:
FRA:S21: Class BTotal Employee Number:
10Description
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.58 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -7.33 | |||||
Beneish M-Score | -6.15 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -24.2 | |||||
3-Year EBITDA Growth Rate | 64.1 | |||||
3-Year EPS without NRI Growth Rate | 74.9 | |||||
3-Year FCF Growth Rate | 80.1 | |||||
3-Year Book Growth Rate | -42.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 56.17 | |||||
14-Day RSI | 50.82 | |||||
3-1 Month Momentum % | 100 | |||||
12-1 Month Momentum % | -80 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.56 | |||||
Quick Ratio | 0.51 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 330.98 | |||||
Days Sales Outstanding | 76.62 | |||||
Days Payable | 511.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -96.5 | |||||
Shareholder Yield % | -24.71 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 93.88 | |||||
Operating Margin % | -7.86 | |||||
Net Margin % | 2.37 | |||||
EBITDA Margin % | 1.35 | |||||
FCF Margin % | 4.15 | |||||
OCF Margin % | 18.69 | |||||
ROE % | 1.03 | |||||
ROA % | 0.72 | |||||
3-Year ROIIC % | -235.3 | |||||
ROC (Joel Greenblatt) % | -165.58 | |||||
ROCE % | -3.43 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PS Ratio | 0.68 | |||||
PB Ratio | 0.49 | |||||
Price-to-Operating-Cash-Flow | 2.7 | |||||
EV-to-EBIT | -7.6 | |||||
EV-to-EBITDA | 44.29 | |||||
EV-to-Revenue | 0.6 | |||||
EV-to-Forward-Revenue | 0.2 | |||||
EV-to-FCF | 14.62 | |||||
Earnings Yield (Greenblatt) % | -13.15 | |||||
FCF Yield % | 5.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
S2Medical AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.626 | ||
| EPS (TTM) (€) | - | ||
| Beta | -4.7486 | ||
| 3-Year Sharpe Ratio | 0.98 | ||
| 3-Year Sortino Ratio | 7.74 | ||
| Volatility % | 480.04 | ||
| 14-Day RSI | 50.82 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.0002 | ||
| 12-1 Month Momentum % | -80 | ||
| 52-Week Range (€) | 0.0001 - 0.006 | ||
| Shares Outstanding (Mil) | 936.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
S2Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
S2Medical AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-21 | In 57 days | ||
| General meeting for 2025 | 2026-06-05 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-05-02 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-20 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2026-02-20 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-22 | 0.00 (+0.00%) | ||
| General meeting for 2024 | 2025-06-16 09:00 | 0.00 (+0.00%) | ||
| Annual report for 2024 | 2025-05-07 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2024 | 2025-02-21 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-08-23 | 0.00 (+0.00%) |
Show
Entries
S2Medical AB Frequently Asked Questions
What is S2Medical AB(FRA:S21)'s stock price today?
The current price of FRA:S21 is €0.00. The 52 week high of FRA:S21 is €0.01 and 52 week low is €0.00.
When is next earnings date of S2Medical AB(FRA:S21)?
The next earnings date of S2Medical AB(FRA:S21) is 2026-08-21.
Does S2Medical AB(FRA:S21) pay dividends? If so, how much?
S2Medical AB(FRA:S21) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on S2Medical AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers